Our top pick for
US stocks
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
ImpediMed Limited is a medical devices business based in Australia. ImpediMed shares (IPD) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. ImpediMed has a trailing 12-month revenue of around $8.4 million. If you're looking to buy shares, check out the steps below.
How to buy shares in ImpediMed
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for ImpediMed . Find the share by name or ticker symbol: IPD. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until ImpediMed reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of ImpediMed . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
ETF investing
Our top pick for
Overall broker
ImpediMed stock price (ASX:IPD)
Use our graph to track the performance of IPD stocks over time.ImpediMed shares at a glance
Information last updated 2021-09-17.
| 52-week range | $0.06 - $0.185 |
|---|---|
| 50-day moving average | $0.1151 |
| 200-day moving average | $0.1157 |
| Target price | $1.16 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.017 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy ImpediMed stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
ImpediMed price performance over time
Historical closes compared with the last close of A$0.11
| 1 week (2021-09-14) | -8.33% |
|---|---|
| 1 month (2021-08-20) | 0.11 |
| 3 months (2021-06-21) | 0.11 |
| 6 months (2021-03-19) | -4.35% |
| 1 year (2020-09-21) | 64.18% |
|---|---|
| 2 years (2019-09-20) | -37.14% |
| 3 years (2018-09-21) | -75.56% |
| 5 years (2016-09-21) | -93.26% |
ImpediMed financials
| Revenue TTM | $8.4 million |
|---|---|
| Gross profit TTM | $6.8 million |
| Return on assets TTM | -42.77% |
| Return on equity TTM | -78.32% |
| Profit margin | -246.24% |
| Book value | 0.017 |
| Market capitalisation | $164.5 million |
TTM: trailing 12 months
ImpediMed share dividends
We're not expecting ImpediMed to pay a dividend over the next 12 months.
Have ImpediMed 's shares ever split?
ImpediMed 's shares were split on a 102:100 basis on 31 May 2009. So if you had owned 100 shares the day before before the split, the next day you'd have owned 102 shares. This wouldn't directly have changed the overall worth of your ImpediMed shares – just the quantity. However, indirectly, the new 2% lower share price could have impacted the market appetite for ImpediMed shares which in turn could have impacted ImpediMed 's share price.
ImpediMed share price volatility
Over the last 12 months, ImpediMed 's shares have ranged in value from as little as $0.06 up to $0.185. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while ImpediMed 's is 3.0143. This would suggest that ImpediMed 's shares are significantly more volatile than the average for this exchange and represent a higher risk.
ImpediMed overview
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was incorporated in 1999 and is headquartered in Pinkenba, Australia.
Stocks similar to ImpediMed
ImpediMed in the news
ImpediMed Announces Presentation at Heart Failure Society of America Annual Scientific Meeting That Demonstrates Utility of SOZO® Digital Health Platform for Heart Failure Patients
FDA Grants Breakthrough Device Designation for ImpediMed's SOZO® Digital Health Platform for Renal Failure
When Can We Expect A Profit From ImpediMed Limited (ASX:IPD)?
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
Why is the Telstra share price running higher today?
Shares in the telecoms operator have jumped nearly 40% over the last 12 months.
-
How to buy IRON Titanium Token (TITAN) in Australia
This guide will show you step-by-step instructions on how to buy the IRON Titanium Token (TITAN) token as well as a list of exchanges you can trade it on.
-
How to buy Wabi (WABI) in Australia
This guide will show you step-by-step instructions on how to buy the Wabi (WABI) token as well as a list of exchanges you can trade it on.
-
How to buy Cindicator (CND) in Australia
This guide will show you step-by-step instructions on how to buy the Cindicator (CND) token as well as a list of exchanges you can trade it on.
-
How to buy MonaCoin (MONA) in Australia
This guide will show you step-by-step instructions on how to buy the MonaCoin (MONA) token as well as a list of exchanges you can trade it on.
-
How to buy Bluzelle (BLZ) in Australia
This guide will show you step-by-step instructions on how to buy the Bluzelle (BLZ) token as well as a list of exchanges you can trade it on.
-
How to buy Whitecoin (XWC) in Australia
This guide will show you step-by-step instructions on how to buy the Whitecoin (XWC) token as well as a list of exchanges you can trade it on.
-
How to buy Storj (STORJ) in Australia
This guide will show you step-by-step instructions on how to buy the Storj (STORJ) token as well as a list of exchanges you can trade it on.
-
Will Qantas shares jump as it locks in travel dates to Fiji, the UK and the US?
Despite the good news, Qantas shares closed flat following the announcement, but that could change in the coming weeks.
-
Why is the Pilbara Minerals share price zooming today?
Shares in the lithium producer are up five-fold over the last 12 months.
Ask an Expert
